Checkpoint Therapeutics, Inc. (CKPT)
4.260
0.00 (0.00%)
Inactive · Last trade price
on May 29, 2025
Checkpoint Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 33.04 | 6.6 | 4.93 | 12.07 | 54.74 | 40.77 | Upgrade
|
| Cash & Short-Term Investments | 33.04 | 6.6 | 4.93 | 12.07 | 54.74 | 40.77 | Upgrade
|
| Cash Growth | 193.94% | 34.01% | -59.16% | -77.95% | 34.25% | 56.35% | Upgrade
|
| Receivables | - | - | - | 0.07 | 0.02 | 0.02 | Upgrade
|
| Prepaid Expenses | 1.12 | 0.87 | 0.45 | 1.15 | 0.98 | 1.8 | Upgrade
|
| Total Current Assets | 34.16 | 7.47 | 5.38 | 13.29 | 55.73 | 42.6 | Upgrade
|
| Total Assets | 34.16 | 7.47 | 5.38 | 13.29 | 55.73 | 42.6 | Upgrade
|
| Accounts Payable | 14.74 | 6.09 | 6.57 | 11.54 | 16.14 | 3.44 | Upgrade
|
| Accrued Expenses | 2.87 | 12.35 | 11.14 | 9.79 | 9.61 | 3.39 | Upgrade
|
| Other Current Liabilities | 0.26 | 1.66 | 0.71 | 11.45 | 0.23 | 0.39 | Upgrade
|
| Total Current Liabilities | 17.87 | 20.1 | 18.43 | 32.77 | 25.98 | 7.22 | Upgrade
|
| Total Liabilities | 17.87 | 20.1 | 18.43 | 32.77 | 25.98 | 7.22 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 398.07 | 350.31 | 297.86 | 241.12 | 223.01 | 173.95 | Upgrade
|
| Retained Earnings | -381.79 | -370.57 | -314.33 | -262.49 | -199.86 | -143.19 | Upgrade
|
| Comprehensive Income & Other | - | 7.64 | 3.42 | 1.89 | 6.6 | 4.62 | Upgrade
|
| Shareholders' Equity | 16.3 | -12.63 | -13.05 | -19.48 | 29.75 | 35.38 | Upgrade
|
| Total Liabilities & Equity | 34.16 | 7.47 | 5.38 | 13.29 | 55.73 | 42.6 | Upgrade
|
| Net Cash (Debt) | 33.04 | 6.6 | 4.93 | 12.07 | 54.74 | 40.77 | Upgrade
|
| Net Cash Growth | 193.94% | 34.01% | -59.16% | -77.95% | 34.25% | 56.35% | Upgrade
|
| Net Cash Per Share | 0.71 | 0.17 | 0.18 | 1.17 | 6.47 | 7.30 | Upgrade
|
| Filing Date Shares Outstanding | 83.06 | 83.76 | 35.69 | 12.95 | 9.06 | 7.52 | Upgrade
|
| Total Common Shares Outstanding | 83.06 | 54.34 | 27.74 | 10.29 | 8.46 | 6.94 | Upgrade
|
| Working Capital | 16.3 | -12.63 | -13.05 | -19.48 | 29.75 | 35.38 | Upgrade
|
| Book Value Per Share | 0.20 | -0.23 | -0.47 | -1.89 | 3.52 | 5.10 | Upgrade
|
| Tangible Book Value | 16.3 | -12.63 | -13.05 | -19.48 | 29.75 | 35.38 | Upgrade
|
| Tangible Book Value Per Share | 0.20 | -0.23 | -0.47 | -1.89 | 3.52 | 5.10 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.